Vaccinating healthcare workers against influenza to protect the vulnerable-Is it a good use of healthcare resources?. A systematic review of the evidence and an economic evaluation

Amanda Burls*, Rachel Jordan, Pelham Barton, Babatunde Olowokure, Beverley Wake, Esther Albon, Jeremy Hawker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

190 Citations (Scopus)

Abstract

Influenza causes substantial mortality in high-risk groups despite targeted vaccination programmes. This paper considers whether it is worth vaccinating healthcare workers (HCWs) against influenza to protect high-risk patients in a series of systematic reviews and an economic evaluation. Eighteen studies are included. Vaccination was highly effective in HCWs, with minimal adverse effects. Two trials assessed patient mortality after vaccinating HCWs, both of which showed a reduction. Despite recommendations, less than 25% of HCW in Europe and the UK are vaccinated. Five studies looked at programmes to increase uptake; these produced increases of 5%-45%. Published economic evaluations did not include patient benefit; therefore, an economic evaluation using UK data was undertaken. In the base case, vaccination was cost saving (£12/vaccinee). In the most pessimistic scenario it cost £405/life-year gained. Effective implementation should be a priority.

Original languageEnglish
Pages (from-to)4212-4221
Number of pages10
JournalVaccine
Volume24
Issue number19
DOIs
Publication statusPublished - 8 May 2006

Keywords

  • Economic evaluation
  • Healthcare workers
  • Influenza vaccination
  • Systematic review

Fingerprint

Dive into the research topics of 'Vaccinating healthcare workers against influenza to protect the vulnerable-Is it a good use of healthcare resources?. A systematic review of the evidence and an economic evaluation'. Together they form a unique fingerprint.

Cite this